St. Jude Medical has launched its Trifecta aortic stented tissue valve in Canada.
The Trifecta is a replacement valve used to treat patients with diseased or damaged aortic heart valves. Its tri-leaflet stented pericardial design helps improve hemodynamic performance, and is implanted into the supra-annular aortic position.
The Trifecta also includes tissue fixation and Linx AC technology, which is designed to reduce tissue mineralization, a common complication.
Lastly, St. Paul, Minn.-based St. Jude said the device’s holder can improve visibility and cuff access for suturing and improve implantation. In addition, its simplified sizing process can grant physicians greater control in choosing proper replacement valves.